Article Text

Download PDFPDF
GMP and preparation in hospital pharmacies
  1. Yvonne Bouwman1,
  2. Lilli Møller Andersen2
  1. 1Laboratory Dutch Pharmacists, KNMP, Den Haag, The Netherlands
  2. 2Department of Quality Assurance, Region Hovedstadens Apotek, Herlev, Denmark
  1. Correspondence to Yvonne Bouwman, Laboratory Dutch Pharmacists, KNMP, Alexanderstraat 11, Den Haag 2514 JL, The Netherlands; y.bouwman{at}


The suitability of good manufacturing practice (GMP) for the quality assurance of the preparation in hospital pharmacies is investigated. It is expected that the recent expansion of GMP with quality by design (QbD) and quality risk management (QRM) will significantly improve the applicability for all types of preparation in hospital pharmacies. QbD and QRM acknowledge the importance of targeting the need of the patient, of a good design and of risk assessment, thereby offering more flexibility to the hospital pharmacist to respond to everyday requests for patient care.

For European hospital pharmacy an elaboration of GMP principles for specific preparation processes is desirable. The development of models for risk assessment will also be very helpful. The usefulness of the Council of Europe Resolution for these aims is discussed. This article aims to provide a small contribution towards a transparent, predictable though flexible and cost-effective pharmacy preparation.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.